DNMT3A and leukemia: Primary leukemic models of DNMT3A/FLT3ITD-mutant mice28 confirmed that in advanced leukemic mice, the frequencies of activated ST2+ Treg cells in the malignant BM were much higher than those found in pre-leukemia or intermediate leukemia mice.